These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5697858)

  • 1. [A volatile alkylating agent in the exhaled air following the administration of Endoxan].
    Rauen HM; Norpoth K
    Klin Wochenschr; 1968 Mar; 46(5):272-5. PubMed ID: 5697858
    [No Abstract]   [Full Text] [Related]  

  • 2. The metabolism of biological alkylating agents.
    Jones AR
    Drug Metab Rev; 1973; 2(1):71-100. PubMed ID: 4359524
    [No Abstract]   [Full Text] [Related]  

  • 3. [The electrophoretic mobility of rat-blood erythrocytes following the administration of Endoxan or nitrogen mustard compounds].
    Rauen HM; Golovinsky E; Norpoth K
    Klin Wochenschr; 1968 Mar; 46(5):276-7. PubMed ID: 5697859
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of cyclophosphamide and nor-nitrogen mustard administration to one-day-old mice.
    Short R; Gibson J
    Experientia; 1971 Jul; 27(7):805-6. PubMed ID: 5139499
    [No Abstract]   [Full Text] [Related]  

  • 5. STUDIES OF THE MODE OF ACTION OF TUMOUR-GROWTH-INHIBITING ALKYLATING AGENTS. V. THE METABOLISM OF 2-CHLOROETHYLARYLAMINES.
    ROBERTS JJ; WARWICK GP
    Biochem Pharmacol; 1963 Dec; 12():1321-8. PubMed ID: 14096419
    [No Abstract]   [Full Text] [Related]  

  • 6. Intestinal absorption of phenesterin (NSC 104469), an alkylating cholesterol ester.
    Feldman EB; Paul H; Cheron R
    Cancer Chemother Rep; 1972 Feb; 56(1):1-7. PubMed ID: 5030805
    [No Abstract]   [Full Text] [Related]  

  • 7. Fate and metabolism of some mutagenic alkylating agents in the mouse. I. Ethyl methanesulfonate and methyl methanesulfonate at sublethal dose in hybrid males.
    Cumming RB; Walton MF
    Mutat Res; 1970 Oct; 10(4):365-77. PubMed ID: 5519682
    [No Abstract]   [Full Text] [Related]  

  • 8. Enzyme-alterable alkylating agents. IX. The enzymatic transformation of some nitrogen mustards in the presence of carbon dioxide: implications in respiration.
    Williamson CE; Kirby JG; Miller JI; Sass S; Kramer SP; Seligman AM; Witten B
    Cancer Res; 1966 Feb; 26(2):323-30. PubMed ID: 5903181
    [No Abstract]   [Full Text] [Related]  

  • 9. A STUDY OF COMPARATIVE CHEMICAL AND BIOLOGICAL ACTIVITIES OF ALKYLATING AGENTS.
    BARDOS TJ; DATTA-GUPTA N; HEBBORN P; TRIGGLE DJ
    J Med Chem; 1965 Mar; 8():167-74. PubMed ID: 14335145
    [No Abstract]   [Full Text] [Related]  

  • 10. Alkylating agents in bronchogenic carcinoma.
    Green RA; Humphrey E; Close H; Patno ME
    Am J Med; 1969 Apr; 46(4):516-25. PubMed ID: 5791000
    [No Abstract]   [Full Text] [Related]  

  • 11. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. 3. TOXICITY DATA ON MONKEYS AND DOGS.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1017+. PubMed ID: 14278900
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of the decomposition of alkylating mutagens of the ethyleneimine series in human lymphocyte cultures].
    Kirichenko OP; Chebotarev AN; Lakovenko KN
    Biull Eksp Biol Med; 1976 May; 81(5):552-3. PubMed ID: 820384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactions of 2,2-dimethylaziridine-type alkylating agents in biological systems II: comparative pharmacokinetics in dogs.
    Lalka D; Jusko WJ; Bardos TJ
    J Pharm Sci; 1975 Feb; 64(2):230-5. PubMed ID: 236372
    [No Abstract]   [Full Text] [Related]  

  • 14. Estrogen receptor interaction with the antitumor agent estradiol mustard.
    Shepherd RE; Huff K; McGuire WL
    J Natl Cancer Inst; 1974 Sep; 53(3):895-7. PubMed ID: 4370003
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of the toxicity and antitumour activity of alkylating drugs by steroids.
    Shepherd R; Harrap KR
    Br J Cancer; 1982 Mar; 45(3):413-20. PubMed ID: 7073935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response curves for agents that impair cell reproductive integrity. A fundamental difference between dose-response curves of antimetabolites and those for radiation and alkylating agents.
    Berenbaum MC
    Br J Cancer; 1969 Jun; 23(2):426-33. PubMed ID: 5788051
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in small intestine epithelium of albino mice caused by chronic treatment with N-mustard substances Endoxan, Trimitan and Degranol with special consideration to Paneth granule cells].
    Eisenhuth I; Geyer G
    Acta Histochem; 1966; 25(1):71-85. PubMed ID: 4962040
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergistic effects of bis(3-methylsulfonyloxypropyl)-amine toluenesulfonate (864-T) with 6-mercaptopurine and other antitumor agents.
    Imamura H; Ikegami K; Okumoto T
    Gan; 1973 Oct; 64(5):427-31. PubMed ID: 4358730
    [No Abstract]   [Full Text] [Related]  

  • 19. Carcinogenicity of alkylating agents.
    Weisburger EK
    Public Health Rep (1896); 1966 Sep; 81(9):772-6. PubMed ID: 4957936
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative study with three alkylating agents: mechlorethamine, cyclophosphamide, and uracil mustard.
    GOLD GL; SALVIN LG; SHNIDER BI
    Cancer Chemother Rep; 1962 Feb; 16():417-9. PubMed ID: 13899670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.